Figure 3From: Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: A double-blind randomised placebo controlled 6-month trialMean changes in SF-36 quality of life score from baseline for type 2 diabetic subjects receiving placebo or paroxetine. Error bars represent 95% CI:s of means. P-values for difference between groups are calculated using ANCOVA with the baseline value as a covariate.Back to article page